severe covid-19

In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including:

• COVID-19 vaccines, including omicron BA.1 bivalent booster
• Risk factors for breakthrough COVID-19 infections
• COVID-19 diagnostics, including digital droplet PCR
• COVID-19 therapeutics, including:
  • Nirmatrelvir plus ritonavir
  • Tixagevimab plus cilgavimab
  • Baricitinib
  • Tocilizumab
  • Inhaled interferon β-1a
• COVID-19 therapeutics and outcomes in patients with immunocompromise
• Long COVID

Presenters:
Princy N. Kumar, MD, FIDSA, MACP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Paul E. Sax, MD
Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Follow along with the downloadable slideset at:
http://bit.ly/3gkJI67

Link to full program:
http://bit.ly/3TSVthM

In episode 17 of this series, Arthur Kim, MD, provides a brief update on the latest COVID-19 treatment options and guidelines. After the update, Dr. Kim answers questions submitted by healthcare professionals on various aspects of COVID-19.  

Presenter:

Arthur Kim, MD
Associate Professor
Department of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts  

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
https://bit.ly/3eDoJF0

In this episode, Part 16 of an ongoing series, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, provides a brief update on emerging COVID-19 variants and their potential impacts on vaccine efficacy. After the update, Professor Lewin answers questions submitted by healthcare professionals on various aspects of COVID-19. 

Presenter:

Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor of Infectious Diseases 
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
Melbourne, Australia

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
https://bit.ly/3eDoJF0

In this episode, Part 15 of an ongoing series, Roger Paredes, MD, PhD, provides a brief update on emerging COVID-19 variants and their potential impacts on the pandemic. After the update, Dr. Paredes answers clinician questions on various aspects of COVID-19.  

Presenter:

Roger Paredes, MD, PhD
Section Chief, Infectious Diseases Department
Germans Trias i Pujol University Hospital 
Head of the Microbial Genomics Group 
IrsiCaixa AIDS Research Institute
Badalona, Catalonia, Spain

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
https://bit.ly/3eDoJF0

In this episode, Part 14 of an ongoing series, Vikramjit Mukherjee, MD, provides a brief update on COVID-19 mortality trends, including the latest data on overall and in-hospital fatality rates. After the update, Dr. Mukherjee answers clinician questions on various aspects of COVID-19. 

Presenter:

Vikramjit Mukherjee, MD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, and Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
http://bit.ly/3eDoJF0

In this episode, Part 13 of an ongoing series, Jens D. Lundgren, MD, DMSc, provides a brief update monoclonal antibody treatments for COVID-19, including the FDA Emergency Use Authorization for bamlanivimab and discusses the recently released information on COVID-19 vaccine efficacy. After the update, Professor Lundgren answers clinician questions on various aspects of COVID-19. 

Presenter:

Jens D. Lundgren, MD, DMSc
Professor
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospitalet, University of Copenhagen
Copenhagen, Denmark

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
https://bit.ly/3eDoJF0

In this episode, Part 12 of an ongoing series, David Heymann, BA, MD, DTM&H, provides a brief update on strategies for moving forward and living safely within the continued COVID-19 pandemic. After the update, Professor Heymann answers clinician questions on various aspects of COVID-19. 

Presenter:

David Heymann, BA, MD, DTM&H 
Professor of Infectious Disease Epidemiology
London School of Hygiene & Tropical Medicine
London, England

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
https://bit.ly/3eDoJF0

In this episode, Part 11 of an ongoing series, Sharon R. Lewin AO, FRACP, PhD, FAHMS, provides a brief update on the role of interferons in COVID-19. After the update, Dr. Lewin answers clinician questions on various aspects of COVID-19. 

Presenter:

Sharon R. Lewin AO, FRACP, PhD, FAHMS
Director, 
The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor of Infectious Diseases 
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program:
https://bit.ly/3eDoJF0